Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up

August 2024 in “ Clinical Cosmetic and Investigational Dermatology ”

Biao Song, Xiaohan Liu, Hongzhong Jin

ixekizumab erythrodermic psoriasis diffuse alopecia alopecia psoriatic skin lesions

TLDR Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

This case report discusses a patient with severe erythrodermic psoriasis (EP) and diffuse alopecia, conditions that significantly affect quality of life. The patient did not respond to conventional treatments but showed complete resolution of both psoriatic skin lesions and alopecia after being treated with ixekizumab for 52 weeks. This suggests that ixekizumab may be an effective treatment option for patients with refractory EP and associated alopecia.

View this study on dovepress.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Autoimmunity and Autoimmune Co-Morbidities in Psoriasis

49 citations , January 2018 in “Immunology”

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

research Psoriatic Alopecia

41 citations , July 2015 in “Clinical and Experimental Dermatology”

Psoriasis can cause temporary or permanent hair loss.

Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia

research Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia

72 citations , February 2011 in “The American Journal of Dermatopathology”

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Similar Research

5 / 75 results

research Subject Index

March 2014 in “Journal of The American Academy of Dermatology”

The document lists various dermatology topics, treatments, and diagnostic methods.

research Immunopathology and Immunotherapy of Inflammatory Skin Diseases

15 citations , January 2022 in “Immune Network/Immune network”

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up

Research cited in this study

research Autoimmunity and Autoimmune Co-Morbidities in Psoriasis

research Psoriatic Alopecia

research Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia

Related Community Posts Join

Similar Research

research An Overview of Growth Factors as the Potential Link Between Psoriasis and Metabolic Syndrome

research Generalized Hypertrichosis Associated with the Use of Interleukin 17 Blockers in 2 Patients with Psoriasis

research Unmet Medical Needs in Chronic, Non-Communicable Inflammatory Skin Diseases

research Subject Index

research Immunopathology and Immunotherapy of Inflammatory Skin Diseases